A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Nonalcoholic Fatty Liver Disease-Reference-Cited by-同舟云学术

A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Nonalcoholic Fatty Liver Disease

Published:2021-09 Issue: Volume: Page:
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Toh Jonathan Zhi Kai,Pan Xin-Hui,Tay Phoebe Wen Lin,Ng Cheng Han,Yong Jie Ning,Xiao Jieling,Koh Jin Hean,Tan En Ying,Tan Eunice Xiang Xuan,Dan Yock Young,Loh Poay Huan,Foo Roger,Chew Nicholas W.S.,Sanyal Arun J.,Muthiah Mark D.^ORCID,Siddiqui Mohammad Shadab

Funder

Gilead Sciences

Bristol-Myers Squibb

Novartis

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference148 articles.

1. Global epidemiology of nonalcoholic fatty liver disease—Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2015

2. Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD);Stepanova;Dig Dis Sci,2013

3. Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease;Anstee;Nat Rev Gastroenterol Hepatol,2018

4. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease;Targher;Atherosclerosis,2007

5. Nonalcoholic fatty liver disease (NAFLD) and risk of cardiac arrhythmias: a new aspect of the liver-heart axis;Mantovani;J Clin Transl Hepatol,2017

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease;2024-02-06

2. A combined analysis of TyG index, SII index, and SIRI index: positive association with CHD risk and coronary atherosclerosis severity in patients with NAFLD;Frontiers in Endocrinology;2024-01-08

3. NAFLD and NAFLD-related HCC in Asia: Burden and Surveillance;Journal of Clinical and Experimental Hepatology;2024-01

4. Clinical Management of Non-alcoholic Steatohepatitis and the Role of the Cardiologist;European Cardiology Review;2023-12-22

5. ST-segment elevation myocardial infarction in the presence of metabolic-associated fatty liver disease;Russian Journal of Cardiology;2023-12-19